Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (3 ops.)
Latest filing published 04 May 2020 for Fennec Pharmaceuticals INC., €4.4M.
Filing timeline
BuySaleEssetifin SpA
Insider track record
Disclosed buys
7
Disclosed sells
3
Signal history
Closed purchases
Market purchases
7
Positive at T+90
100%
Median T+90
+19.1%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -4.9%Entry US$6.50 · Close at T+365 US$6.18
- -36.3%Entry US$9.15 · Close at T+365 US$5.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Essetifin SpA: trading record in brief
Essetifin SpA has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Soligenix, Inc., Regenerx Biopharmaceuticals Inc and Fennec Pharmaceuticals Inc. The record holds 11 filings, for trades running from 29 November 2017 to 30 April 2020.
The open-market side counts 7 purchases for €10.4M alongside 3 sales for €525k. Taken together, the purchases exceed the sales by €9.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2020 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €1.2M.
Most recently, on 4 May 2020, the filings show an open-market purchase worth €4.4M in Fennec Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Essetifin SpA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
768,000 shares@ US$6.25100.0% of flowCommon StockSEC:0001213900-20-010932:0
Canonical exit: 29 Jul 2020 (T+90)
3,133,681 shares@ US$0.06Common StockSEC:0001213900-18-013186:0
11,584,795 shares@ US$0.23Common StockSEC:0001213900-18-002972:0
Canonical exit: 11 Jun 2018 (T+90)
6,348,878 shares@ US$0.23Common StockSEC:0001213900-18-002972:1
Canonical exit: 11 Jun 2018 (T+90)
294,115 shares@ US$8.5032.6% of flowCommon StockSEC:0001213900-17-013250:0
Canonical exit: 12 Mar 2018 (T+90)
271,140 shares@ US$2.1292.4% of flowCommon StockSEC:0001213900-17-012851:0
5,954 shares@ US$2.122.0% of flowCommon StockSEC:0001213900-17-012851:2
16,416 shares@ US$2.125.6% of flowCommon StockSEC:0001213900-17-012851:4
8 of 8 declarations
